Skip to main content
Sexual Medicine logoLink to Sexual Medicine
. 2023 Dec 18;11(6):qfad060. doi: 10.1093/sexmed/qfad060

Will you go the distance? A satisfaction survey of telemedicine in sexual medicine

Gal Saffati 1, Taher Naeem 2, Jordan Kassab 3, Daniela Orozco Rendon 4, Charles Green 5, Larry I Liphsultz 6, Mohit Khera 7,✉
PMCID: PMC10727694  PMID: 38111635

Abstract

Background

The success of telemedicine depends on patient satisfaction with the care that they receive, which is impacted by the ease of use of the technology, quality of the connection, and perceived effectiveness of care.

Aim

The study sought to evaluate patient satisfaction with telemedicine services in a high-volume andrology clinic.

Methods

We included all patients who had a telemedicine appointment between January 1, 2020, and August 22, 2022. Demographic information was gathered, and a satisfaction survey was conducted using REDCap software. Data were grouped into 2 age categories, with ≥50 years as the cutoff (19-50 years; >50 years). The data were analyzed according to age, distance from the patient’s home to our center, and survey responses. Pearson’s chi-square test and ordinal logistic regression analyses were performed.

Outcomes

The main outcome is satisfaction with telemedicine in a men’s sexual health context.

Results

A total of 4071 patients were identified based on attending a telemedicine visit. Hypogonadism was the most common diagnosis. Other diagnoses included erectile dysfunction, varicocele, Peyronie’s disease, vasectomy, and infertility. In total, 613 patients completed the survey, with a mean age of 56.6 years. Older patients were less likely to prefer telemedicine (odds ratio [OR], 0.55; 95% confidence interval [CI], 0.36-0.80; P < .001), less likely to agree to a video visit because of privacy concerns (OR, 0.51; 95% CI, 0.35-0.75; P < .001), and less likely to recommend a telemedicine visit compared with their younger counterparts (OR, 0.37; 95% CI, 0.27-0.51; P < .001). The median distance was 22.4 (interquartile range, 7.5-57.5) miles. However, there was no significant association between distance and patients’ likelihood of preferring telehealth visits, including reviews of outside laboratories and imaging (OR, 1; 95% CI, 0.99-1; P = .35), belief in the quality of care provided via video visits (OR, 0.99, CI 0.99-1; P = .25), and overall preference for telehealth visits (OR, 0.99; 95% CI, 0.99-1; P = .35).

Clinical Implications

Healthcare providers should consider the age of patients when deciding to offer telemedicine while addressing privacy concerns to provide adequate reassurance to patients who may have concerns about the quality of care provided through telemedicine.

Strengths and Limitations

Our study achieved a substantial sample size that reached statistical significance. Conducted at a single academic center, our study was constrained, possibly introducing biases related to the institution’s advanced telemedicine system. Geographic and diagnostic limitations could lead to regional biases, affecting the generalizability of the findings.

Conclusion

Older patients exhibited a lower inclination toward preferring telemedicine, along with decreased odds of endorsing in-person visits.

Keywords: hypogonadism, telehealth, sexual health, andrology

Introduction

Telemedicine is defined as the use of electronic communication technologies, such as videoconferencing and phone consultations, to provide remote clinical healthcare services. Before the COVID-19 pandemic, telemedicine was primarily used as a supplement to in-person care, allowing for increased access to specialty care in underserved areas.1 However, the pandemic has prompted a rapid expansion of telemedicine, with many healthcare providers shifting to virtual consultations as a primary means of medical care delivery.2

Telemedicine has been gaining popularity in the field of urology prior to the COVID-19 pandemic. However, there were several barriers to adoption, such as reimbursement issues, lack of resources and time, and liability concerns, according to a survey conducted by the American Urological Association’s Telemedicine Workgroup.3 Despite these barriers, a recent study using a state insurance claims database showed that urology was leading among surgical subspecialties in terms of telehealth conversions of encounters during the pandemic.4 According to the 2020 American Urological Association annual census data, 71.5% of urologists confirmed participating in telemedicine, a significant increase from 11.9% in the previous year.3

Moreover, telemedicine has the potential to especially benefit the field of sexual medicine, as it allows for the safe management of common male sexual dysfunctions such as erectile dysfunction, premature ejaculation, and hypogonadism through remote encounters.5 The COVID-19 pandemic has also highlighted the importance of telehealth in sexual medicine, as telemedicine encounters associated with male sexual medicine made up a significantly larger portion of outpatient practice.6

The success of telemedicine ultimately depends on the patient’s experience. While telehealth may be more convenient for providers with the ability to see more patients in a shorter amount of time, it is the patient’s satisfaction with the care as well as the quality of care that they receive that ultimately determines the success of telemedicine. Factors that can affect patient satisfaction with telemedicine include ease of use of the technology, quality of the video or audio connection, and perceived effectiveness of the care received. Ensuring that patients have positive experiences with telemedicine is crucial for its continued success. Therefore, we sought to evaluate patient satisfaction with telemedicine services at our high-volume andrology clinic.

Methods

An institutional review board–approved study was conducted to evaluate the telemedicine experience among male patients at our center. A query of the EPIC electronic medical record system was performed to identify all male patients who had at least 1 telemedicine appointment between January 1, 2020, and August 22, 2022. Basic demographic information, including age, race, encounter date, and International Classification of Diseases–Tenth Revision diagnosis codes, was also collected. Only patients seen by 2 high-volume andrologists at our center were included. A satisfaction survey, utilizing the REDCap (Research Electronic Data Capture) software, was administered to the eligible patients. The survey consisted of 5 sections, addressing basic information, purpose of visit, relationship and communication, quality of care, and satisfaction, and included a total of 17 questions. Sixteen of the questions were multiple choice, while 1 question was open-ended, seeking feedback on participants’ willingness to consider a video visit in the future. The full survey is included as supplemental material (Appendix 1). Data collection occurred from October 2022 to December 2022. To further analyze the data, respondents were subdivided by age, with a cutoff of 50 years of age, into 2 groups for comparison (19-50 years of age; >50 years of age). For each relevant question, a cross-tabulation between age group and responses was made, with subsequent Pearson’s chi-square test. Likewise, when using age as a continuous variable, a proportional odds logistic regression analysis was made while we used the dichotomized age groups as a predictor to get a measure of association. Finally, we calculated the distance in miles from the patient’s registered home address to our center and later compared it with their recorded responses to measure any relation with distance and satisfaction.

Results

Study population

A total of 4071 patients who had at least 1 telemedicine appointment between January 1, 2020, and August 22, 2022, were identified. Of these, 158 (3.8%) were Asian, 297 (7.3%) were Black or African American, 239 (5.8%) were Hispanic, 2700 (66.3%) were White, and 230 (5.6%) identified as other. A total of 447 (10.9%) patients had no recorded races. A total of 3121 (76.6%) patients had an office visit via video, while 950 (23.3%) visits were conducted over the telephone. The mean age of the study population was 50.1 years, with variation among racial groups. Asian participants had a mean age of 43.7 years, Black or African American participants had a mean age of 51.1 years, Hispanic participants had a mean age of 42.2 years, and White participants had a mean age of 51.9 years. The study population was characterized by a wide range of diagnoses. The most common diagnosis was hypogonadism, which accounted for 89.1% of patients. This was followed by erectile dysfunction, with 4.6%. In addition, varicocele accounted for 2.2% of the patients, and Peyronie’s disease accounted for 2.2% of the patients. Vasectomy accounted for 1.2% of the patients, while Infertility accounted for 0.8% of the patients.

Responses

A total of 613 patients completed the survey, with a mean age of 56.6 years. Respondent characteristics are summarized in Table 1. All survey responses are included in Appendix 1, while relevant questions and answers are summarized in Table 2.

Table 1.

Demographic characteristics of survey respondents.

Age
<50 y 201 (32.8)
≥50 y 412 (67.2)
Race/ethnicity
American Indian or Alaska Native 2 (0.3)
Asian Indian 1 (0.1)
Black or African American 23 (3.7)
Hispanic 22 (3.5)
Other Asian 8 (1.3)
Other Pacific Islander 1 (0.1)
White 487 (79.4)
Declined to answer racial/ethnic identification 40 (6.5)
None of the above 29 (4.7)
Diagnosis
Hypogonadism 313 (51.1)
Erectile dysfunction and hypogonadism 134 (21.9)
Erectile dysfunction 64 (10.4)
Infertility 32 (5.2)
Don’t know or don’t remember diagnosis 15 (2.5)
Infertility and hypogonadism 14 (2.3)
Peyronie’s disease 13 (2.1)
Subjective overall general state of health
Fully active without restrictions 208 (34.0)
Minimal difficulty engaging in most activities 98 (16.0)
Somewhat difficult to engage in some activities 158 (25.7)
Very difficult for me to engage in some activities 80 (13.0)
Very difficult for me to engage in most activities 69 (11.2)

Values are n (%).

Table 2.

Relevant survey responses stratified by age.

Question Survey sample, % of subgroup
<50 years of age ≥50 years of age
1. How likely would you be to meet with your Urology provider via video call from your home when you do NOT need new labs/imaging, your physician can review outside labs/imaging, and no physical exam/procedure is needed?
Very unlikely 1.0 4.4
Somewhat unlikely 1.5 5.3
Equally likely or unlikely 4.5 6.3
Somewhat likely 13.9 15.3
Very likely 79.1 68.7
7. I believe the provider is able to do his/her job adequately despite not being able to conduct a physical exam at every appointment.
Strongly disagree 2.0 4.1
Moderately disagree 1.0 7.3
Equally agree and disagree 8.5 13.6
Moderately agree 18.4 28.2
Strongly agree 70.1 46.8
8. I feel confident that video conferencing communications are private and secure.
Strongly disagree 0.5 3.6
Moderately disagree 0.5 4.4
Equally agree and disagree 5.0 8.5
Moderately agree 18.9 21.1
Strongly agree 75.1 62.4
9. I would prefer to see a provider over video rather than travel to a physical appointment.
Strongly disagree 5.5 14.1
Moderately disagree 7.0 16.0
Equally agree and disagree 26.4 25.5
Moderately agree 13.9 17.0
Strongly agree 47.3 27.4
10. I believe I will get the same quality of care via video visit as I would during an in-person visit.
Strongly disagree 3.0 11.2
Moderately disagree 7.0 16.0
Equally agree and disagree 17.9 19.2
Moderately agree 16.9 23.1
Strongly agree 55.2 30.6
12. How satisfied are you with the telehealth visits you have had at our center?
Very dissatisfied 1.5 4.9
Somewhat dissatisfied 1.5 2.7
Equally satisfied and dissatisfied 10.4 16.5
Somewhat satisfied 13.4 15.8
Very satisfied 73.1 60.2
14. If you had to do it again, would you prefer a telehealth visit or an in-person visit?
Telehealth 75.1 55.1
In-person 24.9 44.9
15. How likely are you to recommend a telehealth visit with our center over an in-person visit to friends or family?
Very unlikely 0.5 9.5
Somewhat unlikely 4.5 9.0
Equally likely or unlikely 12.4 22.6
Somewhat likely 22.4 19.9
Very likely 60.2 39.1

In terms of preference for telemedicine over in-person visits, 61.2% of younger patients preferred telemedicine compared with 44.4% of older patients. Overall, it was found that older patients were significantly less likely to prefer telemedicine visits (odds ratio [OR], 0.43; 95% confidence interval [CI], 0.31-0.58; P < .001). This was further supported when we stratified by age, and a downward trend in preference for telemedicine was observed, with older patients being less likely to prefer telemedicine to their younger counterparts OR 0.55; 95% CI, 0.36-0.80; P < .001). With each year of age, the odds of a patient preferring telemedicine decreased (OR, 0.97; 95% CI, 0.96-0.98; P < .001). Older patients were less likely to recommend a telemedicine visit than younger patients (OR, 0.37; 95% CI, 0.26-0.51; P < .001). Younger patients were found to be more satisfied with telemedicine visits than older patients (OR, 1.85; 95% CI 1.32-2.70; P < .001). Furthermore, with each additional year of age, the odds of endorsing an in-person visit increased (OR, 1.03; 95% CI, 1.01-1.04; P < .001).

Delving into specific concerns that patients had with telemedicine, there were concerns among older patients about the quality, security, and limitations of telemedicine. When assessing the patients’ beliefs about the ability of providers to perform their job competently without physical examinations, older patients disagreed that providers could perform their job correctly with telemedicine appointments (P < .001) Regarding privacy and security concerns, younger patients were more confident that video visits were private and secure than older patients (94% vs 83%). Older patients were less likely to agree to a video visit because of privacy concerns (OR, 0.51; 95% CI, 0.35-0.75; P < .001), and with each additional year of age, the agreement with the question decreased (OR, 0.98; 95% CI, 0.96-0.99; P < .001). In terms of quality of care provided and patient satisfaction, older patients were also less likely to agree that the quality of care would be the same between video visits and in-person appointments than younger patients (OR, 0.37; 95% CI, 0.27-0.50; P < .001).

Distance

The median distance was 22.4 (interquartile range, 7.5-57.5) miles. When evaluating the relationship between distance and patient satisfaction with telehealth visits, we found no significant association between distance and the likelihood of a patient preferring telehealth visits for review of outside labs and imaging without the need for new tests, physical examinations, or procedures (OR, 1; 95% CI, 0.99-1; P < .01). There was also no significant decrease in belief in the provider’s ability to perform their job adequately despite the absence of a physical exam at every appointment (OR, 0.99, CI 0.99-1; P < .01) or confidence in the privacy and security of video visits (OR, 0.99; 95% CI, 0.99-1; P < .01). There was no preference for telehealth visits over traveling for in-person visits (OR, 1.33; 95% CI, 0.99-1.8; P < .01) related to distance. There was no relationship between the belief in the same quality of care via video visit as in-person visit (OR, 1; 95% CI, 0.99-1; P < .01) that was related to distance. Last, the overall preference for telehealth visits (OR, 0.99; 95% CI, 0.99-1; P < .01) was not significantly impacted by distance.

Discussion

The inclusion of telemedicine across healthcare providers has proven to be critical, allowing patients to receive medical consultations, diagnoses, and treatment from clinicians located in other areas without the need to travel long distances. This is especially crucial for patients with chronic conditions that require frequent medical attention. Urology, as a telemedicine subspecialty, has potentially even more useful implications because of the high prevalence of chronic disorders experienced by both male and female patients.7 Additionally, as specialty care is perceived as less accessible due to its high cost of service, telemedicine can help remediate this barrier by reducing the time and cost associated with patient travel.8 The study underscores the potential advantages of telemedicine in urology.

Our findings explores several factors that shape patients’ inclinations toward telemedicine, such as age and privacy concerns. Specifically, the results indicated that older patients exhibited a reduced preference for telemedicine and were less likely to recommend it to others. Furthermore, our data revealed emerging concerns regarding privacy as a significant impediment to telemedicine adoption. According to the results, patients who had to travel long distances to reach the healthcare center reported higher satisfaction levels with telehealth visits. This observation could assist healthcare providers in identifying patients who are likely to gain the most from telemedicine and refining their services to better suit their requirements. These insights can help healthcare providers to develop more effective strategies for integrating telemedicine into clinical practice and improving patient satisfaction. The implications of this study are as follows: healthcare providers should consider the age of patients when deciding to offer telemedicine while addressing privacy concerns to provide adequate reassurance to patients who may have concerns about the quality of care provided through telemedicine.

Although the sample size was quite substantial, encompassing hundreds of patient inputs, a low response rate was observed in our study (15.1%). This lack of response may be due to the sensitive nature of urology, which limits what patients feel comfortable sharing online. Additionally, because this study was conducted at a single academic center, it limited the range of patients that we were able to assess. This can lead to biases that stem from the institution’s ability to perform telemedicine adequately. The institution in which this study was conducted has a well-established protocol for telemedicine in place that may make it a more viable option than in other institutions where the system may be less developed. Thus, the results could be reflective of this iteration of telemedicine and not necessarily reflect just telemedicine as its own distinct service. There may be regional biases associated with our data because of this limitation in the geographic and diagnostic scope; thus, these results may not be generalizable to the general population. However, we believe that this potential drawback may be mitigated by a large sample size, including subjects with diverse backgrounds, and varying diagnosis within sexual medicine. To build on these data, future studies should include a larger sample size and multiple centers to increase the generalizability of the results and ensure reliability and external validity.9 Another potential source of bias stems from the survey only being distributed among patients who had done a telemedicine visit, which could introduce that bias that these patients would be more likely to prefer a telemedicine visit than the general population. Further, it would be of note to investigate other potential confounding variables, such as socioeconomic status, education level, previous experience with telemedicine, and health status, as indicated by the Charlson Comorbidity Index. Because these factors are highly variable among individuals, they may lead to further divided results. Clinicians can provide more comprehensive recommendations in their counseling by knowing what various populations are likely to prefer.

This study highlights the importance of further research to refine our understanding of the relationship between telemedicine, patient satisfaction, and exceptional healthcare, particularly regarding the influence of socioeconomic status, education level, and overall health status on reported telehealth satisfaction in specific patient subpopulations. Moreover, future studies could explore the potential of telemedicine in the diagnosis and management of specific urological conditions, ultimately providing valuable insights into the benefits of telemedicine in the field of urology. Furthermore, this study has implications beyond the realm of urology; by expanding into different medical specialties, we can uncover telemedicine’s transformative impact across healthcare to have a more comprehensive scope of its relationship with patient satisfaction. As telemedicine continues to evolve, further research and development in this area could have a substantial impact on the healthcare industry, improving patient outcomes and ultimately contributing to a healthier and more connected society.

Conclusion

Patient preferences and concerns when introducing telemedicine services, particularly for the elderly population, are critically important in ensuring the ultimate success of telemedicine implementation. This knowledge can help healthcare providers tailor their services to meet the needs of their patients and enhance the adoption of telemedicine.

Supplementary Material

STROBE_Telehealth_qfad060

Acknowledgments

None.

Contributor Information

Gal Saffati, Scott Department of Urology, Baylor College of Medicine, 7200 Cambridge Street, Houston, Texas, 77030, United States.

Taher Naeem, Scott Department of Urology, Baylor College of Medicine, 7200 Cambridge Street, Houston, Texas, 77030, United States.

Jordan Kassab, Texas Tech University Health Sciences Center School of Medicine, 3601 4th Street, Lubbock, Texas 79430, United States.

Daniela Orozco Rendon, Scott Department of Urology, Baylor College of Medicine, 7200 Cambridge Street, Houston, Texas, 77030, United States.

Charles Green, Department of Pediatrics, McGovern Medical School, University of Texas, 6431 Fannin Street, Houston, Texas 77030, United States.

Larry I Liphsultz, Scott Department of Urology, Baylor College of Medicine, 7200 Cambridge Street, Houston, Texas, 77030, United States.

Mohit Khera, Scott Department of Urology, Baylor College of Medicine, 7200 Cambridge Street, Houston, Texas, 77030, United States.

Author contribution

Conception and Design: G.S., T.N., J.K., Larry Lipshultz, M.K. Acquisition of Data: G.S., T.N., J.K..

Analysis and Interpretation of Data: G.S., T.N., J.K., C.G. Drafting the Article: G.S., T.N., J.K., D.O.R. Revising It for Intellectual Content: G.S., T.N., J.K., D.O.R., C.G., L.L., M.K. Final Approval of the Completed Article: G.S., T.N., J.K., D.O.R., C.G., L.L., M.K.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Appendix 1.

Survey responses

Question Options N (%)
0. Which statement best describes your overall general state of health? 1 - It is VERY DIFFICULT for me to engage in MOST activities 15 (2.4)
2 - It is VERY DIFFICULT for me to engage in SOME activities 22 (3.6)
3 - It is SOMEWHAT DIFFICULT for me to engage in SOME activities 87 (14.2)
4 - I am able to engage in most activities with MINIMAL difficulty 180 (29.3)
5 - I am fully active without any restrictions 309 (50.4)
1. How likely would you be to meet with your Urology provider via video call from your home when you do NOT need new labs/imaging, your physician can review outside labs/imaging, and no physical exam/procedure is needed? 1 - Very unlikely 20 (3.3)
2 - Somewhat unlikely 25 (4.1)
3 - Equally likely and unlikely 35 (5.7)
4 - Somewhat likely 91 (14.8)
5 – Very likely 442 (72.1)
2. Undergoing an initial clinic visit with a new urology provider? 1 - Strongly Disagree 111 (18.1)
2 - Moderately Disagree 115 (18.7)
3 - Equally Agree and Disagree 100 (16.3)
4 - Moderately Agree 139 (22.7)
5 - Strongly Agree 148 (24.1)
3. Discussing new symptoms and/or concerns? 1 - Strongly Disagree 36 (5.8)
2 - Moderately Disagree 47 (7.6)
3 - Equally Agree and Disagree 53 (8.6)
4 - Moderately Agree 149 (24.3)
5 - Strongly Agree 328 (53.5)
4. Discussing diagnosis, treatment, and/or follow-up recommendations? 1 - Strongly Disagree 34 (5.6)
2 - Moderately Disagree 39 (6.4)
3 - Equally Agree and Disagree 47 (7.7)
4 - Moderately Agree 123 (20)
5 - Strongly Agree 370 (60.3)
5. Reviewing imaging and laboratory test findings? 1 - Strongly Disagree 30 (4.9)
2 - Moderately Disagree 26 (4.2)
3 - Equally Agree and Disagree 46 (7.5)
4 - Moderately Agree 131 (21.3)
5 - Strongly Agree 380 (62)
6. Completing postoperative follow-up? 1 - Strongly Disagree 58 (9.5)
2 - Moderately Disagree 71 (11.6)
3 - Equally Agree and Disagree 71 (11.6)
4 - Moderately Agree 133 (21.7)
5 - Strongly Agree 280 (45.7)
7. I believe the provider is able to do his/her job adequately despite not being able to conduct a physical exam at every appointment. 1 - Strongly Disagree 21 (3.4)
2 - Moderately Disagree 32 (5.2)
3 - Equally Agree and Disagree 73 (11.9)
4 - Moderately Agree 153 (24.9)
5 - Strongly Agree 334 (54.5)
8. I feel confident that video conferencing communications are private and secure. 1 - Strongly Disagree 16 (2.6)
2 - Moderately Disagree 19 (3.1)
3 - Equally Agree and Disagree 45 (7.3)
4 - Moderately Agree 125 (20.4)
5 - Strongly Agree 408 (66.5)
9. I would prefer to see a provider over video rather than travel to a physical appointment. 1 - Strongly Disagree 69 (11.2)
2 - Moderately Disagree 80 (13)
3 - Equally Agree and Disagree 158 (25.8)
4 - Moderately Agree 98 (16.0)
5 - Strongly Agree 208 (34.0)
10. I believe I will get the same quality of care via video visit as I would during an in-person visit. 1 - Strongly Disagree 52 (8.5)
2 - Moderately Disagree 80 (13.1)
3 - Equally Agree and Disagree 115 (18.8)
4 - Moderately Agree 129 (21.0)
5 - Strongly Agree 237 (38.7)
12. How satisfied are you with the telehealth visits you have had at our center? 1 - Strongly Disagree 23 (3.8)
2 - Moderately Disagree 14 (2.3)
3 - Equally Agree and Disagree 89 (14.5)
4 - Moderately Agree 92 (15.0)
5 - Strongly Agree 395 (64.4)
13. Did your video visit with your Baylor College of Medicine Urology provider start on time? 1 - Yes 475 (77.5)
2 - No 138 (22.5)
14. If you had to do it again, would you prefer a telehealth visit or an in-person visit? 1 - Telehealth 378 (61.7)
2 - In-person 235 (38.3)
15. How likely are you to recommend a telehealth visit with Baylor
College of Medicine Urology over an in-person visit to friends or family?
1 - Very unlikely 40(6.5)
2 - Somewhat unlikely 46 (7.5)
3 - Equally likely or unlikely 118(19.2)
4 - Somewhat likely 127(20.7)
5 - Very likely 282(46.0)

Conflict of Interest

M.K. has served as a consultant for AbbVie, Marius, Tolmar, Endo, Petros, Boston Scientific, and Coloplast; and is an investor in Sprout. L.L. has served as a consultant for AbbVie, Aytu BioScience, Contraline, Endo Pharmaceuticals, and Lipocine; and speaker for Boston Scientific and Endo Pharmaceuticals; and advisor for Inherent Biosciences.

References

  • 1. Puskin DS. Opportunities and challenges to telemedicine in rural America. J Med Syst. 1995;19(1):59–67. 10.1007/BF02257191. [DOI] [PubMed] [Google Scholar]
  • 2. Butaney M, Rambhatla A. The impact of COVID-19 on urology office visits and adoption of telemedicine services. Curr Opin Urol. 2022;32(2):152–157. 10.1097/MOU.0000000000000957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Badalato GM, Kaag M, Lee R, Vora A, Burnett A. Role of telemedicine in urology: contemporary practice patterns and future directions. Urol Pract. 2020;7(2):122–126. 10.1097/UPJ.0000000000000094. [DOI] [PubMed] [Google Scholar]
  • 4. Patel SY, Mehrotra A, Huskamp HA, Uscher-Pines L, Ganguli I, Barnett ML. Variation in telemedicine use and outpatient care during the COVID-19 pandemic in the United States. Health Aff (Millwood). 2021;40(2):349–358. 10.1377/hlthaff.2020.01786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Dooley AB, De La HN, Baum N. Use of telemedicine for sexual medicine patients. Sex Med Rev. 2020;8(4):507–517. 10.1016/j.sxmr.2020.06.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Rabinowitz MJ, Kohn TP, Ellimoottil C, Alam R, Liu JL, Herati AS. The impact of telemedicine on sexual medicine at a major academic Center during the COVID-19 pandemic. Sex Med. 2021;9(3):100366. 10.1016/j.esxm.2021.100366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Shashar R, Chatumi S, Amiel G. Gender-specific medicine in urology. Harefuah. 2021;160(9):603–607. [PubMed] [Google Scholar]
  • 8. Bellinger JD, Hassan RM, Rivers PA, Cheng Q, Williams E, Glover SH. Specialty care use in US patients with chronic diseases. Int J Environ Res Public Health. 2010;7(3):975–990. 10.3390/ijerph7030975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Leung L. Validity, reliability, and generalizability in qualitative research. J Fam Med Prim Care. 2015;4(3):324–327. 10.4103/2249-4863.161306. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

STROBE_Telehealth_qfad060

Articles from Sexual Medicine are provided here courtesy of Oxford University Press

RESOURCES